Boston Scientific Corporation
BSX
$52.68
-$0.87-1.63%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.62B | 20.08B | 19.35B | 18.49B | 17.55B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.62B | 20.08B | 19.35B | 18.49B | 17.55B |
| Cost of Revenue | 6.40B | 6.27B | 6.13B | 5.91B | 5.54B |
| Gross Profit | 14.21B | 13.81B | 13.22B | 12.58B | 12.02B |
| SG&A Expenses | 7.07B | 6.89B | 6.67B | 6.49B | 6.22B |
| Depreciation & Amortization | 910.00M | 897.00M | 894.00M | 874.00M | 862.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.51B | 16.10B | 15.63B | 15.11B | 14.31B |
| Operating Income | 4.11B | 3.97B | 3.72B | 3.39B | 3.24B |
| Income Before Tax | 3.74B | 3.38B | 3.27B | 3.00B | 2.48B |
| Income Tax Expenses | 183.00M | 492.00M | 485.00M | 502.00M | 454.00M |
| Earnings from Continuing Operations | 3.56K | 2.89K | 2.78K | 2.50K | 2.02K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.00M | 6.00M | 8.00M | 8.00M | 8.00M |
| Net Income | 3.57B | 2.90B | 2.79B | 2.51B | 2.03B |
| EBIT | 4.11B | 3.97B | 3.72B | 3.39B | 3.24B |
| EBITDA | 5.50B | 5.34B | 5.07B | 4.70B | 4.53B |
| EPS Basic | 2.40 | 1.96 | 1.89 | 1.70 | 1.38 |
| Normalized Basic EPS | 1.79 | 1.72 | 1.62 | 1.50 | 1.26 |
| EPS Diluted | 2.39 | 1.94 | 1.87 | 1.68 | 1.37 |
| Normalized Diluted EPS | 1.77 | 1.70 | 1.60 | 1.49 | 1.25 |
| Average Basic Shares Outstanding | 5.93B | 5.92B | 5.91B | 5.90B | 5.89B |
| Average Diluted Shares Outstanding | 5.98B | 5.98B | 5.97B | 5.96B | 5.95B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |